147 related articles for article (PubMed ID: 11682124)
21. Heavy and light chain variable single domains of an anti-DNA binding antibody hydrolyze both double- and single-stranded DNAs without sequence specificity.
Kim YR; Kim JS; Lee SH; Lee WR; Sohn JN; Chung YC; Shim HK; Lee SC; Kwon MH; Kim YS
J Biol Chem; 2006 Jun; 281(22):15287-95. PubMed ID: 16551636
[TBL] [Abstract][Full Text] [Related]
22. Effect of VL and VH consensus sequence-specific primers on the binding and expression of a mini-molecule antibody directed towards human gastric cancer.
Li J; Wang Y; Wang Z; Dong Z
Chin Med Sci J; 2000 Sep; 15(3):133-9. PubMed ID: 12903769
[TBL] [Abstract][Full Text] [Related]
23. Expression and characterization of recombinant single-chain Fv and Fv fragments derived from a set of catalytic antibodies.
Kim SH; Schindler DG; Lindner AB; Tawfik DS; Eshhar Z
Mol Immunol; 1997; 34(12-13):891-906. PubMed ID: 9464525
[TBL] [Abstract][Full Text] [Related]
24. Production of high-affinity human monoclonal antibody fab fragments to the 19-kilodalton C-terminal merozoite surface protein 1 of Plasmodium falciparum.
Cheng XJ; Hayasaka H; Watanabe K; Tao YL; Liu JY; Tsukamoto H; Horii T; Tanabe K; Tachibana H
Infect Immun; 2007 Jul; 75(7):3614-20. PubMed ID: 17452466
[TBL] [Abstract][Full Text] [Related]
25. Fabs specific for 8-oxoguanine: control of DNA binding.
Bespalov IA; Bond JP; Purmal AA; Wallace SS; Melamede RJ
J Mol Biol; 1999 Nov; 293(5):1085-95. PubMed ID: 10547287
[TBL] [Abstract][Full Text] [Related]
26. Affinity maturation of a high-affinity human monoclonal antibody against the third hypervariable loop of human immunodeficiency virus: use of phage display to improve affinity and broaden strain reactivity.
Thompson J; Pope T; Tung JS; Chan C; Hollis G; Mark G; Johnson KS
J Mol Biol; 1996 Feb; 256(1):77-88. PubMed ID: 8609615
[TBL] [Abstract][Full Text] [Related]
27. Interferon response following infection with genetically similar isolates of viral haemorrhagic septicaemia virus (VHSV) exhibiting contrasting virulence in rainbow trout.
Campbell S; McBeath A; Secombes C; Snow M; Collet B
Fish Shellfish Immunol; 2011 Jan; 30(1):287-94. PubMed ID: 21056106
[TBL] [Abstract][Full Text] [Related]
28. A recombinant Fab neutralizes dengue virus in vitro.
Thullier P; Lafaye P; Mégret F; Deubel V; Jouan A; Mazié JC
J Biotechnol; 1999 Apr; 69(2-3):183-90. PubMed ID: 10361725
[TBL] [Abstract][Full Text] [Related]
29. Effect of VH and VL consensus sequence-specific primers on the binding and neutralizing potential of a single-chain FV directed towards HuIFN-gamma.
Froyen G; Hendrix D; Ronsse I; Fiten P; Martens E; Billiau A
Mol Immunol; 1995 May; 32(7):515-21. PubMed ID: 7783754
[TBL] [Abstract][Full Text] [Related]
30. In vitro assembly of repertoires of antibody chains on the surface of phage by renaturation.
Figini M; Marks JD; Winter G; Griffiths AD
J Mol Biol; 1994 May; 239(1):68-78. PubMed ID: 8196048
[TBL] [Abstract][Full Text] [Related]
31. Virulence marker candidates in N-protein of viral haemorrhagic septicaemia virus (VHSV): virulence variability within VHSV Ib clones.
Ito T; Kurita J; Mori KI; Skall HF; Lorenzen N; Vendramin N; Gedsted Andersen N; Einer-Jensen K; Olesen NJ
Dis Aquat Organ; 2018 Mar; 128(1):51-62. PubMed ID: 29565253
[TBL] [Abstract][Full Text] [Related]
32. Modification of the first constant domain of heavy chain enabled effective folding of functional anti-forskolin antigen-binding fragment for sensitive quantitative analysis.
Yusakul G; Sakamoto S; Tanaka H; Morimoto S
Biotechnol Prog; 2019 Jul; 35(4):e2822. PubMed ID: 31008567
[TBL] [Abstract][Full Text] [Related]
33. Both VH and VL chains of polyreactive IgM antibody are required for polyreactivity: expression of Fab in Escherichia coli.
Cheung SC; Takeda S; Notkins AL
Clin Exp Immunol; 1995 Aug; 101(2):383-6. PubMed ID: 7648724
[TBL] [Abstract][Full Text] [Related]
34. Construction and characterization of a Fab recombinant protein for Japanese encephalitis virus neutralization.
Wu SC; Lin YJ; Chou JW; Lin CW
Vaccine; 2004 Nov; 23(2):163-71. PubMed ID: 15531033
[TBL] [Abstract][Full Text] [Related]
35. Fast neutralization/immunoperoxidase assay for viral haemorrhagic septicaemia with anti-nucleoprotein monoclonal antibody.
Lorenzo G; Estepa A; Coll JM
J Virol Methods; 1996 Apr; 58(1-2):1-6. PubMed ID: 8783145
[TBL] [Abstract][Full Text] [Related]
36. "Diabodies": small bivalent and bispecific antibody fragments.
Holliger P; Prospero T; Winter G
Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6444-8. PubMed ID: 8341653
[TBL] [Abstract][Full Text] [Related]
37. Phylogenetic analysis of viral haemorrhagic septicaemia virus (VHSV) isolates from France (1971-1999).
Thiéry R; de Boisséson C; Jeffroy J; Castric J; de Kinkelin P; Benmansour A
Dis Aquat Organ; 2002 Nov; 52(1):29-37. PubMed ID: 12517003
[TBL] [Abstract][Full Text] [Related]
38. Retention of neutralising activity by recombinant anti-pneumolysin antibody fragments.
Garcia M; Strachan G; Porter AJ; Harris WJ
FEMS Immunol Med Microbiol; 1998 Nov; 22(3):225-31. PubMed ID: 9848683
[TBL] [Abstract][Full Text] [Related]
39. EFab domain substitution as a solution to the light-chain pairing problem of bispecific antibodies.
Cooke HA; Arndt J; Quan C; Shapiro RI; Wen D; Foley S; Vecchi MM; Preyer M
MAbs; 2018; 10(8):1248-1259. PubMed ID: 30215570
[TBL] [Abstract][Full Text] [Related]
40. Three-dimensional structure of the Fab fragment of a neutralizing antibody to human rhinovirus serotype 2.
Tormo J; Stadler E; Skern T; Auer H; Kanzler O; Betzel C; Blaas D; Fita I
Protein Sci; 1992 Sep; 1(9):1154-61. PubMed ID: 1338980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
